Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
Chen B, Yao W, Li X, Lin G, Chu Q, Liu H, Du Y, Lin J, Duan H, Wang H, Xiao Z, Sun H, Liu L, Xu L, Xu Y, Xu F, Kong Y, Pu X, Li K, Wang Q, Li J, Li B, Xia Y, Wu L. Chen B, et al. Among authors: xu l, xu f, xu y. Br J Cancer. 2024 Feb;130(3):450-456. doi: 10.1038/s41416-023-02519-0. Epub 2023 Dec 18. Br J Cancer. 2024. PMID: 38110665 Free PMC article. Clinical Trial.
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study.
Chen B, Wang J, Pu X, Li J, Wang Q, Liu L, Xu Y, Xu L, Kong Y, Li K, Xu F, Liang S, Cardona AF, Wu L. Chen B, et al. Among authors: xu l, xu f, xu y. Transl Lung Cancer Res. 2022 Oct;11(10):2111-2124. doi: 10.21037/tlcr-22-697. Transl Lung Cancer Res. 2022. PMID: 36386462 Free PMC article.
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab.
Zhang Y, Pei Z, Chen B, Qu Y, Dong X, Yu B, Wang G, Xu F, Lu D, He Z, Chen B, Ma L, Wang M, Li B, Xia M, Zheng B, Huo Y. Zhang Y, et al. Among authors: xu f. Pharmacol Res. 2024 Sep;207:107340. doi: 10.1016/j.phrs.2024.107340. Epub 2024 Aug 5. Pharmacol Res. 2024. PMID: 39111557 Free article. Clinical Trial.
Efficacy and safety of CalliSpheres® microspheres drug-eluting beads transarterial chemoembolization in GCLM combined trans-arterial infusion therapy for treating primary focus of gastric cancer: a multi-center retrospective study.
Zhao GS, Song YX, Sun JB, Liu S, Xu F, Ma J, Li C, Gao F, Zhou J, Wang RY, Liang SN. Zhao GS, et al. Among authors: xu f. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):1009-1016. doi: 10.1080/14737140.2023.2239496. Epub 2023 Jul 28. Expert Rev Anticancer Ther. 2023. PMID: 37475534
Effects of Remimazolam on Intraoperative Frontal Alpha Band Power Spectrum Density and Postoperative Cognitive Function in Older Adults Undergoing Lower Extremity Fractures Surgeries: A Randomized Controlled Trial.
Wu H, Tian S, Ma H, Zhou W, Feng S, Meng L, Ou J, Xu F, Zhang Z. Wu H, et al. Among authors: xu f. Clin Interv Aging. 2024 Dec 31;19:2195-2205. doi: 10.2147/CIA.S496437. eCollection 2024. Clin Interv Aging. 2024. PMID: 39764357 Free PMC article. Clinical Trial.
15,186 results
You have reached the last available page of results. Please see the User Guide for more information.